摘要
当高血压合并糖代谢异常时,会导致原有病情明显加重。在糖耐量减低(impaired glucose tolerance,IGT)阶段,心脑血管疾病发病率就会显著升高。同时高血压是2型糖尿病患者发生大血管和微血管合并症的重要诱因,此类患者应该强化降压治疗。高血压患者糖代谢异常发生率较高,临床上应重视高血压患者糖代谢异常的筛查,可以通过非药物或药物治疗使其血压、血糖达标。本文就国内外有关高血压患者合并糖代谢异常的预后研究结果进行了综述。
Hypertension will be more serious when it is complicated with glucose metabolic disorder.The incidence rate of cardiovascular and cerebrovascular diseases in hypertensive patients will increase significantly as impaired glucose tolerance(IGT) happens.Because hypertension leads to complications in large and capillary vessels in type 2 diabetes patients,intensive treatment of pressure release is recommended by many guidelines.Screening of glucose metabolic disorder in hypertensive patients should be paid more attention.Both nondrug and pharmacotherapy can make blood pressure and blood glucose return to the standard.This review focuses on prognosis of patients with hypertension complicated with glucose metabolic disorder at home and abroad in recent years.
出处
《首都医科大学学报》
CAS
北大核心
2011年第5期634-639,共6页
Journal of Capital Medical University
关键词
高血压
糖代谢异常
糖耐量降低
预后
hypertension
glucose metabolic disorder
impaired glucose tolerance
prognosis